Mirabegron

Mirabegron is a beta-3 adrenergic agonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.

 

It is commercialised in Europe by Astellas pharma as Betmiga.